Apr 27, 2020
TriLink BioTechnologies and Imperial College London Announce Collaboration to Produce saRNA for Covid-19 Vaccine Development
Apr 22, 2020
Caris Life Sciences Launches Whole Exome Sequencing with MI Exome
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Feb 28, 2020
North America & EMEA RNA Purification Life Science Dashboard 2020
Sep 04, 2019
RNA Expert Dr. Phillip Sharp Joins as Advisor to Skyhawk Therapeutics
Sep 27, 2018
Computer Scientists at Worcester Polytechnic Institute Are Developing Tools to Probe the Molecular Basis of Complex Diseases
Jun 26, 2018
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk's STAR* Technology Platform
May 22, 2018
National Institutes of Health Awards Envisagenics with $1.5M Phase II SBIR Grant
May 01, 2018
Envisagenics Named North American Winner of Innovate.AI Competition, Receives $1M Investment from M12 and Madrona Venture Group
Jan 23, 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Dec 11, 2017
Caris Life Sciences Identifies New Mechanism of Action for an Aptamer with Therapeutic Potential to Treat Non-Hodgkin Lymphoma
Nov 30, 2017
Envisagenics Closes $2.35M Seed Round and Launches SpliceCore Platform
Nov 28, 2017
Dynamk Capital Invests in Envisagenics to Advance AI Drug Discovery
Sep 26, 2017
1CellBiO Signs Reseller and License Agreement with Hangzhou Chengyuan Genomics Co. to Deliver Groundbreaking Single Cell Analysis Technology to China